Sign in Subscribe
Cancer

Breakthrough in Cancer Gene Therapy: Tunable Membrane Penetration-directed Signal Amplification for MMP-2 Detection

Strategic Insights

— 2 min read

Researchers at Wenzhou Medical University have made a significant breakthrough in cancer gene therapy with the development of a facile and sensitive electrochemical biosensing method for detecting matrix metalloproteinase-2 (MMP-2), a potential indicator in most solid tumors. This innovative method uses a well-designed peptide probe with tunable membrane penetration activity, which allows for the selective identification of cancer patients. The research, funded by the Natural Science Foundation of Zhejiang Province and the National Natural Science Foundation of China, has been successfully applied to MMP-2 determination in mimic tumor microenvironment and serum samples.

Key Takeaways:

  • The researchers have developed a novel electrochemical biosensing method for MMP-2 detection, which shows a wider linear range from 50 fg/mL to 10 ng/mL and a low limit of detection at 13.3 fg/mL.
  • The method uses a peptide probe with tunable membrane penetration activity, which is initially inhibited by a blocking domain through electrostatic interaction.
  • Once the probe is selectively recognized and cleaved by MMP-2, its membrane penetration activity is switched on, leading to large amounts of methylene blue molecules being released from liposomes.
  • The method has been successfully applied to MMP-2 determination in mimic tumor microenvironment and serum samples, and has proved the feasibility of the selective identification of cancer patients.
  • This research suggests a potential use in the determination of protease-specific tumor biomarkers for pan-cancer screening.
  • The method has been peer-reviewed and published in Sensors and Actuators B: Chemical, a reputable scientific journal.
  • The researchers have used a well-designed peptide probe with tunable membrane penetration activity, which allows for the selective identification of cancer patients.
  • The study was conducted by a team of researchers led by Ming Tu at Wenzhou Medical University in collaboration with Guozhang Zhou, Yizhang Wu, Yulin Xiong, Yue Cao, Jing Zhao, Kai Zhang, and Wensheng Liu.

Statistics:

  • The method shows a wider linear range from 50 fg/mL to 10 ng/mL.
  • The method has a low limit of detection at 13.3 fg/mL.
  • The study was funded by the Natural Science Foundation of Zhejiang Province and the National Natural Science Foundation of China.
  • The research was peer-reviewed and published in Sensors and Actuators B: Chemical, a reputable scientific journal.
  • The study was conducted by a team of researchers led by Ming Tu at Wenzhou Medical University in collaboration with Guozhang Zhou, Yizhang Wu, Yulin Xiong, Yue Cao, Jing Zhao, Kai Zhang, and Wensheng Liu.

Sources:

  • NewsRx. Study Data from Wenzhou Medical University Update Knowledge of Cancer Gene Therapy (Tunable Membrane Penetration-directed Signal Amplification for Electrochemical Determination of Matrix Metalloproteinase-2 In Cancer Diagnosis). Cancer Weekly. May 20, 2025; p 31.
  • Elsevier Science Sa. Sensors and Actuators B: Chemical. 2025;431.

Read more